Healthcare provider profile · identity verified

Robert John Pizziketti, M.D.

Family Practice · YORK, PA · NPI 1003830423

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	664	215
Lisinopril	Lisinopril	602	177
Amlodipine Besylate	Amlodipine Besylate	467	142
Levothyroxine Sodium	Levothyroxine Sodium	377	113
Omeprazole	Omeprazole	367	125
Fluticasone Propionate	Fluticasone Propionate	318	117
Losartan Potassium	Losartan Potassium	316	94
Metoprolol Succinate	Metoprolol Succinate	296	88
Hydrochlorothiazide	Hydrochlorothiazide	281	90
Metformin Hcl	Metformin Hcl	273	85
Meloxicam	Meloxicam	253	78
Simvastatin	Simvastatin	246	76
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	236	68
Furosemide	Furosemide	203	68
Gabapentin	Gabapentin	203	66
Pantoprazole Sodium	Pantoprazole Sodium	194	65
Tamsulosin Hcl	Tamsulosin Hcl	184	59
Metoprolol Tartrate	Metoprolol Tartrate	179	56
Famotidine	Famotidine	171	57
Eliquis	Apixaban	159	42
Albuterol Sulfate Hfa	Albuterol Sulfate	151	56
Sertraline Hcl	Sertraline Hcl	147	45
Buspirone Hcl	Buspirone Hcl	144	46
Allopurinol	Allopurinol	138	42
Lovastatin	Lovastatin	138	39
Zolpidem Tartrate	Zolpidem Tartrate	134	34
Alprazolam	Alprazolam	129	28
Clopidogrel	Clopidogrel Bisulfate	123	43
Azithromycin	Azithromycin	111	83
Trazodone Hcl	Trazodone Hcl	104	35
Carvedilol	Carvedilol	103	32
Glipizide	Glipizide	95	33
Atenolol	Atenolol	94	28
Pravastatin Sodium	Pravastatin Sodium	93	29
Bupropion Hcl Sr	Bupropion Hcl	85	27
Diclofenac Sodium	Diclofenac Sodium	85	21
Lorazepam	Lorazepam	84	31
Amoxicillin	Amoxicillin	82	68
Duloxetine Hcl	Duloxetine Hcl	77	27
Montelukast Sodium	Montelukast Sodium	75	24
Tramadol Hcl	Tramadol Hcl	75	24
Rosuvastatin Calcium	Rosuvastatin Calcium	72	27
Citalopram Hbr	Citalopram Hydrobromide	68	24
Warfarin Sodium	Warfarin Sodium	67	17
Mupirocin	Mupirocin	65	41
Hydralazine Hcl	Hydralazine Hcl	64	19
Jardiance	Empagliflozin	64	16
Spironolactone	Spironolactone	61	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	59	19
Synthroid	Levothyroxine Sodium	58	19
Paroxetine Hcl	Paroxetine Hcl	56	16
Terazosin Hcl	Terazosin Hcl	55	15
Alendronate Sodium	Alendronate Sodium	54	17
Fluoxetine Hcl	Fluoxetine Hcl	54	14
Finasteride	Finasteride	53	16
Potassium Chloride	Potassium Chloride	50	17
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	48	suppressed
Ozempic	Semaglutide	47	12
Trulicity	Dulaglutide	46	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	45	45
Shingrix	Varicella-Zoster Ge/As01b/Pf	44	41
Amitriptyline Hcl	Amitriptyline Hcl	43	13
Meclizine Hcl	Meclizine Hcl	42	20
Celecoxib	Celecoxib	41	17
Clonazepam	Clonazepam	41	15
Escitalopram Oxalate	Escitalopram Oxalate	40	15
Methylprednisolone	Methylprednisolone	40	36
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	20
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	suppressed
Nabumetone	Nabumetone	36	11
Venlafaxine Hcl Er	Venlafaxine Hcl	36	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	34	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	34	29
Enalapril Maleate	Enalapril Maleate	32	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	31	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	31	20
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	30	suppressed
Ketoconazole	Ketoconazole	29	15
Metformin Hcl Er	Metformin Hcl	29	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	27	suppressed
Carisoprodol	Carisoprodol	27	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Hydrocortisone	Hydrocortisone	25	12
Azelastine Hcl	Azelastine Hcl	24	14
Flecainide Acetate	Flecainide Acetate	24	suppressed
Gemfibrozil	Gemfibrozil	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Latanoprost	Latanoprost	22	suppressed
Mometasone Furoate	Mometasone Furoate	22	16
Valacyclovir	Valacyclovir Hcl	22	suppressed
Entresto	Sacubitril/Valsartan	21	suppressed
Valsartan	Valsartan	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Jantoven	Warfarin Sodium	20	suppressed
Naproxen	Naproxen	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	19
Mirtazapine	Mirtazapine	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Prednisone	Prednisone	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	11
Verapamil Er	Verapamil Hcl	18	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	17	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	17	17
Donepezil Hcl	Donepezil Hcl	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Cephalexin	Cephalexin	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	13
Estradiol	Estradiol	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	suppressed
Metronidazole	Metronidazole	15	suppressed
Nitroglycerin	Nitroglycerin	15	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Fluconazole	Fluconazole	14	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Nystatin	Nystatin	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Apriso	Mesalamine	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Temazepam	Temazepam	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Anastrozole	Anastrozole	11	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error